CEO’S MESSAGE

Welcome to Mundipharma.

Right from the start, we are all about people and we are about patients.

The Mundipharma story, spanning over six decades, is one that brings together a visionary approach and a pioneering spirit – and is best told through our patients, our employees and the communities in which we serve. Our dedication to putting patients at the heart of every business decision has ensured that we continue to grow and more importantly, improve the lives of the people who need our medicines the most.

That foundation has not only delivered significant results, but is a reflection of our ability to convert entrepreneurism and innovation into business success.

We are focused on the transformation of Mundipharma’s business in the important Emerging Markets – by leveraging our global leadership in pain and, through a shared spirit of innovation, building a growing presence in oncology, oncology supportive care, ophthalmology, respiratory, consumer healthcare and other specialty areas.

Our unique approach to partnerships has given us the opportunity to establish a strong market presence that covers the world’s pharmaceutical markets. Today we are an innovative company, with several thousand employees across the Emerging Markets serving more than four billion patients and a distribution network covering six continents. And this is just the beginning of our story in this region.

While we continue to grow and develop our business in all reaches of the globe, we also recognise that it is our people, innovation and our values that enable us to do what we do. We understand that we have a higher purpose – especially as the work we do has the ability to improve the quality of people’s lives everywhere. On a personal level, I am extremely proud to have this opportunity to lead this company and retain its focus and its core values.

Mundipharma is a company that will never lose sight of its heritage and history – and because of that, we are confident about the future as we actively pursue innovative new treatments and new opportunities in order to Bring More To Life.
 

Raman Singh

CEO
Mundipharma

© Mundipharma (Hong Kong) Limited. 2019
  Units 801B-802A, Tower B Manulife Financial Centre
  223-231 Wai Yip Street, Kwun Tong, Kowloon, Hong Kong
The product information provided in this site is intended only for residents in Hong Kong and the products discussed herein may have different product labeling in different countries/regions.

TOP

Please note:
By clicking on this link, you will be leaving Mundipharma website. Mundipharma is not responsible for any of the content you encounter beyond this site.

 

 

 

Please note:
By clicking on this link, you will be leaving Mundipharma website. Mundipharma is not responsible for any of the content you encounter beyond this site.

 

 

 

Condition of Use
The information contained in this section is intended for healthcare professional for reference purpose only. By clicking the "I agree" button (below), you agree to be bound by this Condition of Use.

 

 

 

If you would like to receive more information about Betadine®, please visit:

 

 

Condition of Use
The information contained in this section is intended for healthcare professional for reference purpose only. By clicking the "I agree" button (below), you agree to be bound by this Condition of Use.

 

 

 

Condition of Use
The information contained in this section is intended for healthcare professional for reference purpose only. By clicking the "I agree" button (below), you agree to be bound by this Condition of Use.

 

 

 

Condition of Use
The information contained in this section is intended for healthcare professional for reference purpose only. By clicking the "I agree" button (below), you agree to be bound by this Condition of Use.

 

 

 

Condition of Use
The information contained in this section is intended for healthcare professional for reference purpose only. By clicking the "I agree" button (below), you agree to be bound by this Condition of Use.